Ind-Swift Laboratories Ltd approves Q2 FY27 results, reporting standalone revenue of ₹234.89 crore and net profit of ₹31.03 crore
- Revenue rose 26.2% sequentially and 50.1% year on year.
- EBITDA was ₹42.33 crore, with an 18.0% operating margin; net profit grew 26.9% sequentially and 254.4% year on year.
- Auditors’ limited-review reports were unqualified; exceptional items were a net expense of ₹57.97 lakh.